Heartseed Inc.

219A・Growth Market・Pharmaceuticals

Official website

Heartseed Inc.

219A・Growth Market・Pharmaceuticals

Official website

Heartseed Inc.219A

Reference Indicators

Market Cap

366¥100M

P/E (Forecast)

—

P/B

5.1x

Dividend Yield (Forecast)

0.00%

ROE

2.8%

EV/EBITDA

91.5x

Financial Summary

Unit: ¥M

Item	2024Oct 2024	2025Dec 2025
Net Sales	873	3,026
Gross Profit	873	3,026
SG&A Expenses	1,912	2,754
Operating Income	-1,038	272
Non-operating Income	262	58
Non-operating Expenses	41	41
Ordinary Income	-818	288
Pre-tax Income	-818	288
Income Taxes	-5	98
Net Income	-812	190
EBITDA	-996	325
Gross Margin	100.0%	100.0%
Operating Margin	-118.9%	9.0%
ROA	-11.5%	2.5%
ROE	-12.3%	2.8%

Latest Reports

ENVALITH doesn't cover this company yet, so no reports are available.

Want to read a report? Request coverage!

Recent Disclosures

Financial Highlights

Net Sales
3,026¥M+246.4
EBITDA
325¥M+132.6
ROE
2.8%+15.1
ROA
2.5%+14.0
EPS
8.4¥+117.1
BPS
314.6¥+5.8
DPS
0¥